ABSTRACT
Prediction of conversion from Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) is a challenging task due to involvement of many genetic and environmental factors leading to neurodegeneration. Several Genome Wide Association Studies (GWAS) have been conducted to understand genetic risk factors of AD, however, there are not many GWAS studies that find the genetic factors of conversion from MCI to AD. In this study, we aim to find potential genetic markers causing conversion from MCI to AD and build a machine learning model to predict the conversion. To this end, we used genetic variation data of 809 patients in Alzheimer's Disease Neuroimaging Initiative (ADNI). We processed the genetic data by merging SNPs information of all patients into a single set of PLINK files, which served as input for the GWAS analysis. SNPs were filtered based on call rate, minor allele frequency and Hardy-Weinberg equilibrium cut-off. Samples were also filtered to remove any linkage using sample call rate, inbreeding coefficient, kinship coefficient and linkage disequilibrium cut-off. After the filtration, we calculated negative log p-value for the remaining SNPs in association with the phenotype (i.e., converter vs. non-converter). We repeated this step for other traits such as ventricle size, hippocampus size, and Tau protein concentration to record different loci on chromosomes influencing each trait. The presence or absence of significant SNPs will be used to create a deep learning model to predict the progression of AD in a patient using only genetic information.
Index Terms
- GWAS analysis to compute genetic markers of progression to Alzheimer's disease
Recommendations
Random Forest and Gene Networks for Association of SNPs to Alzheimer's Disease
BSB 2013: 8th Brazilian Symposium on Advances in Bioinformatics and Computational Biology - Volume 8213Machine learning methods, such as Random Forest (RF), have been used to predict disease risk and select a set of single nucleotide polymorphisms (SNPs) associated to the disease on Genome-Wide Association Studies (GWAS). In this study, we extracted ...
Mapping enhancer and chromatin accessibility landscapes charts the regulatory network of Alzheimer's disease
Abstract BackgroundEnhancers are regulatory elements that target and modulate gene expression and play a role in human health and disease. However, the roles of enhancer regulatory circuit abnormalities driven by epigenetic alterations in Alzheimer's ...
Highlights- Identified DMA enhancers across brain regions of Alzheimer's disease.
- Enhancer-TF-target regulatory circuits were associated with brain microenvironment.
- DMA enhancers exhibited distinct chromatin accessibility at single-cell ...
Further Evidence for Role of Promoter Polymorphisms in TNF Gene in Alzheimer’s Disease
Intelligent Computing Theories and ApplicationAbstractTumor necrosis factor (TNF) expression level is associated with regulating effects on Alzheimer’s disease (AD) development. And several TNF SNPs have been reported to associate with AD, however, it is unclear whether TNF SNPs could affect TNF ...
Comments